Financials in USD. Standardized financial statements.
A compact view of how Medical Developments International Limited turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $39.06M | $33.15M | $32.34M | $21.94M | $25.27M | $22.54M | $20.88M | $17.46M | $18.35M | $15.47M |
| Revenue Growth? | +17.8% | +2.5% | +47.4% | -13.2% | +12.1% | +7.9% | +19.6% | -4.8% | +18.6% | 0.0% |
| Cost of Revenue? | $9.63M | $8.78M | $34.85M | $25.00M | $8.60M | $8.80M | $6.69M | $5.10M | $5.76M | $4.26M |
| Gross Profit? | $29.43M | $24.37M | -$2.52M | -$3.06M | $16.67M | $13.74M | $14.18M | $12.36M | $12.58M | $11.21M |
| Gross Margin? | +75.3% | +73.5% | -7.8% | -13.9% | +66.0% | +61.0% | +67.9% | +70.8% | +68.6% | +72.5% |
| Operating Expenses? | $26.35M | $35.41M | $17.76M | $12.63M | $21.91M | $11.87M | $13.01M | $11.92M | $10.12M | $8.91M |
| Operating Income? | $3.07M | -$11.04M | -$14.43M | -$15.70M | -$5.24M | $1.87M | $3.17M | $2.07M | $3.50M | $3.56M |
| EBITDA? | $1.67M | -$29.45M | -$4.28M | -$12.86M | -$13.44M | $3.03M | $3.89M | $2.22M | $3.80M | $3.42M |
| Income Before Tax | $168,000 | -$32.93M | -$7.49M | -$15.91M | -$14.98M | $321,000 | $1.55M | $301,000 | $2.46M | $2.30M |
| Income Tax Expense | $74,000 | $8.07M | -$1.88M | -$3.50M | -$2.41M | -$58,000 | $513,000 | $58,000 | $643,000 | $732,000 |
| Net Income? | $94,000 | -$40.99M | -$5.61M | -$12.41M | -$12.56M | $379,000 | $1.04M | $243,000 | $1.82M | $1.57M |
| EPS? | $0.00 | $-0.47 | $-0.07 | $-0.17 | $-0.18 | $0.01 | $0.02 | $0.00 | $0.03 | $0.03 |
| Diluted EPS? | $0.00 | $-0.47 | $-0.07 | $-0.17 | $-0.18 | $0.01 | $0.02 | $0.00 | $0.03 | $0.03 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality